Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
Posted in | Nanomedicine

Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum

Published on September 29, 2010 at 6:15 AM

Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the 9th Annual BIO Investor Forum at 4:30 p.m. PT on Tuesday, October 5, 2010, at the Palace Hotel in San Francisco, CA.

Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.

The BIO Investor Forum is a national investor conference featuring private and emerging public companies. The meeting attracts healthcare venture capital and public market investors and research analysts. In addition, the BIO Investor Forum draws business development executives from global pharmaceutical and biotechnology companies.

Source: http://www.arrowheadresearch.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit